View All News

Lygos Closes Series B Financing

We are excited to announce the close of Lygos’ $15.5MM Series B round of financing. Led by IA Ventures and First Round Capital, these funds will be used to accelerate commercialization of our pipelined products and expand our technology platform. Having successfully developed a bio-based route to malonates, we now look forward to bringing new aspartic, glycolic, and lactic acid technologies to market, among others.

Read more:

Lygos Raises $15.5 Million to Accelerate Delivery of Clean and Sustainable Biology-Based Performance Materials. Globe Newswire (July 2018)

More News
September 16, 2019
Lygos Secures Strategic Investment from CJ CheilJedang to Accelerate Growth in Bioengineering Industries
September 5, 2019
Lygos Upgrades Technology Capabilities to Accelerate Microbial Cell Factory Development Timelines
July 8, 2019
Lygos Announces Bio-DEM™ Product Qualified at Metric Ton Scale for Sirrus’ Chemilian™ and Forza™ Product Lines